Robot arm could make prostate biopsies more accurate

NCT ID NCT02871726

Recruiting now Diagnosis Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a robotic device that helps guide the ultrasound probe during prostate biopsies. The goal is to see if it can improve cancer detection and reduce errors compared to the standard freehand method. About 483 men scheduled for their first prostate biopsy will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TRUS-Robot (a robotic device to guide ultrasound probe during prostate biopsy)
What this could lead to: If successful, this robotic system could make prostate biopsies more accurate, reducing missed cancers and unnecessary repeat procedures.
What could go wrong: This is a device trial comparing robotic assistance to standard biopsy. It may not show a clear benefit, and device malfunctions or complications are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.